300 Irish jobs axed by health firm after ‘difficult decision to cease operations' as workers face ‘devastating future'
HUNDREDS of Irish jobs are set to be scrapped after a major health firm announced redundancies here.
Some 300 jobs are to be lost with the closure of Carelon Global Solutions Ireland in Castletroy in
Advertisement
2
Labour's Conor Sheehan described the announcement as 'deeply worrying'
Credit: Niall Carson/PA Wire
The
A spokesperson confirmed: 'The process to close operations will occur over the course of the next several months, and we expect it to be completed by the end of 2025.
'We greatly appreciate the work and dedication from associates in Ireland over the past few years and are committed to supporting them during this time."
Carelon, formerly known as Legato Health
Advertisement
Read more in Money
The firm previously said it was considering its future in Ireland after a review of its business operations, and an examination of the changing healthcare landscape globally.
He said: 'This is not just a business decision—it has real human consequences. These are dedicated staff who have contributed to the company's success, and they deserve more than silence or ambiguity in return.
'Carelon must recognise the human impact of this closure and act swiftly. The workers must be given clarity on what comes next.
Advertisement
Most read in The Irish Sun
Exclusive
'Will there be redeployment? What are the redundancy terms? How are their rights and entitlements going to be protected? The worst thing we can do is leave people in limbo.
'We also need to ask: where is the Minister for Enterprise? These
'MUST ENGAGE WITH WORKERS'
The TD added: 'I want to make clear that my office is open to any of the impacted workers in Limerick who need advice, support or advocacy at this difficult time.
'I will continue to stand up for them and raise this issue at the highest level.
Advertisement
"Carelon must act responsibly. They must engage with workers now.'
2
Hundreds of Irish jobs are set to be scrapped at Carelon Global Solutions Ireland
Credit: Getty Images - Getty
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
an hour ago
- Irish Examiner
John Whelan: Ireland behind the curve in pharma R&D amid Pfizer call
Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order signed by President Trump on May 12, effectively forcing drug companies to commit to aligning their US prices with 'the lowest price of a set of economic peer countries''. At the meeting of the Pharmaceutical Research and Manufacturers of America (PhRMA) with the Trump administration, Pfizer chief executive Albert Bourla called for the US government to lead an initiative to increase overall drug spending outside the US. While the exact mechanism of implementing the Trump executive order to reduce drug prices in the US remains unclear, the Pfizer chief proposed an alternative solution, suggesting that other countries should spend a certain percentage of their GDP per capita on innovative medicines. In an attempt to lead on the recommendation, he added that Pfizer could consider not making its drugs available for government reimbursement in some countries if the US carries through on its price control and other countries don't increase their prices. Effectively, Mr Bourla, who chairs the pharma industry lobby group PhRMA, suggested the US should push for a Nato-type agreement, which commits each country to a minimum 2% of their national GDP on defence spending. And whereas there may be good logic in the Pfizer proposal, any commitment of this nature will likely create major challenges for Ireland, as OECD and World Bank figures show Ireland lagging well behind other countries in research and development expenditure. In 2022, the last year for which finalised figures have been released, US pharmaceutical companies' R&D spending amounted to 2.33% of the nation's GDP. There is no comparable figures for the Irish market, in terms of pharmaceutical industry expenditure in research and development. However, the figures available from the World Bank and the OECD for years 2022/2023 show that total R&D for all industry as a percentage of GDP, in Ireland was 0.9%. This is well below the EU average of 2.29%, and even further below countries like the US at 3.6% and Israel at 6.3% who invest more heavily in R&D than Ireland. Economists have inferred that Trump is leveraging unfavourable policies such as drastically lowering prices points of US drugs and tariffs on imports, to coerce the pharmaceutical industry to increase investments in the US. Several large pharma companies, including Eli Lilly, Merck & Co, and Bristol Myers Squibb, have unveiled major US investments planned for the next few years in attempt to curry favour with the Trump administration. But noticeably Pfizer remains an exception to that trend. However, Mr Bourla stated that Pfizer has invested in US manufacturing and will continue to do so, but risks from those Trump policies are making it difficult for the company to commit further. "I don't think it makes sense to make announcements of future investments in an environment that is very fluid,' Mr Bourla said. That suggests Pfizer, one of our largest and longest-term investors in the pharmaceuticals space, is unlikely to back off its Irish investments anytime soon. However , we need to heed the Pfizer CEO's call for more R&D support in Europe, which clearly includes Ireland. Besides Pfizer, many pharma companies are leveraging the United States' threat of tariffs on drug imports to push for policy changes in the EU. In a letter sent on April 11 to European Commission President Ursula von der Leyen, 32 pharma companies demanded more favourable policies in order for them to maintain operations in the EU . In the same letter they say that policy changes are needed to ensure Europe remains a location to research, develop, and manufacture medicines. The CEOs also included in their letter that European countries should rethink their drug pricing policies and enable a better commercial environment for innovative medicines. Ireland's Research and Innovation Act 2024 , replaces Science Foundation Ireland in an attempt to fast forward the provision for the funding of research and innovation, but this caters for all fields of activity and neither commits to double the level of funding to €2bn per year needed to reach EU level, nor does it commit to meet the specific requirements of the pharma industry.
Irish Examiner
an hour ago
- Irish Examiner
Infrastructure taskforce to be updated on project delays
The Government's recently-formed infrastructure taskforce is to be briefed on the delays besetting key projects across the country. Public expenditure minister Jack Chambers is to chair the second meeting of the 'accelerating infrastructure taskforce', which is focusing on removing barriers to delivery. At the meeting, it is expected that members will be briefed on specific projects that have been subject to different types of delay. This will include the M28 Ringaskiddy-to-Cork road, alongside water and energy projects across the country. One government source said taskforce members will examine what changes to current processes and project requirements could be made to 'strike the appropriate balance between the controls and procedures governing the delivery of major capital projects'. It is understood the taskforce will submit a report that identifies the specific barriers to infrastructure delivery to the Government by the end of July. It comes after one member of the taskforce, Economic and Social Research Institute chairman Sean O'Driscoll, told the Irish Examiner there were 'catastrophic consequences' facing Ireland's water, energy, and transport networks if 'radical and brave decisions are not taken to ensure projects get completed quicker'. Mr O'Driscoll said the Government needed to accept that there is a 'national crisis' in Irish infrastructure, while adding that public servants are more 'scared' of the public accounts committee than the economy declining. Meanwhile, Taoiseach Micheál Martin is to bring an update on the Government's expert group on conveyancing and probate, with the group set to be extended for a further six months. The group is recommending a more permanent structure to take over dealing with issues surrounding probate and conveyancing in December. Conveyancing and probate are the legal processes for transferring a property from one person to another, or for when an individual dies. The Government's aim through the group is to speed up the conveyancing and probate processes, to avoid houses being left empty due to being stuck in lengthy processes. There is a target of an eight-week turnaround time for solicitors to complete conveyancing, from the acceptance of an offer to its close. A new e-probate system is expected to be launched later this year, which the Government believes will significantly reduce processing times and delays. The group is continuing to develop proposals around the establishment of an e-conveyancing system over the coming six months. Cabinet will also be briefed around the implementation of the Dublin City taskforce report. It is understood that proposals within the implementation plan include the establishment of a development body for regeneration projects in the city. This would include the future use of the GPO on O'Connell Street, but would also look at regenerating shops, apartments, and offices within the city. Elsewhere, a meeting between transport minister Darragh O'Brien and justice minister Jim O'Callaghan took place last week to discuss options for the establishment of a new transport police. It is understood that any such force would operate outside An Garda Síochána and would not be under the remit of the Department of Justice. Government sources indicated that the current preferred model would see the transport police led by the National Transport Authority, with powers similar to that of the airport police.
Irish Examiner
7 hours ago
- Irish Examiner
RTÉ coverage of Pope Francis's funeral and election of Pope Leo cost €150k
RTÉ's coverage of the death of Pope Francis and the subsequent election of Pope Leo cost the broadcaster €150,000. Figures released under Freedom of Information show that the broadcaster's extensive coverage of the death of the pontiff included €4,200 in venue hire and over €1,200 in subsistence costs for management grade staff from Radio 1, with the overall costs of travel, hotels, and subsistence coming in at around €150,000 in total. RTÉ provided hours of coverage across its platforms upon the death of Pope Francis in April, including his funeral and the election of American cardinal Robert Francis Prevost as the 267th leader of the Catholic Church and the successor to Francis as Pope Leo. The station's output included a special broadcast of its flagship Prime Time programme with records showing that staff airfares and hotels for that show cost around €3,600. While the cost of flights was one of the larger outlays, some airfares came in at as little as €13. The world's media and thousands of pilgrims descended on the Vatican City upon the death of Pope Francis, with mourners standing in line for hours to pay their final respects while his body lay in state in St Peter's Basilica ahead of his funeral. That was followed by coverage ahead of the papal conclave which lasted just over a day and a half and resulted in the election of the first American pope. In response to the FOI request, RTÉ said: "In relation to hotels, it is not possible to extract a precise spend on this alone so we have included 'staff subsistence' which would cover this and other costs. "Similar to civil and public servants, RTÉ personnel were paid to a set 'day rate' which would cover the cost of accommodation as well as food etc. "[T]he costs incurred were necessary to allow RTÉ fulfil its obligations to provide comprehensive coverage of two major global events across radio, television and online in both Irish and English. "Those who travelled provided many hours of coverage for all radio and television news and current affairs programming as well as online content spanning the days between the death of Pope Francis to the election of Pope Leo." Read More Pope Leo XIV calls for aid to reach Gaza in first general audience
